GlassScriptPhysician profile
Wendy H Stevens
NPI 1548220239
$6,134.03
in general payments reported to CMS, 2019-2025
35 companies · $140 in 2025
The $140 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,489 · 2022: $1,573 · 2023: $1,596 · 2024: $1,337 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,072.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,072.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $880.56 | 2021-2025 | Lokelma, Airsupra, Breztri |
| Bayer Healthcare Pharmaceuticals INC. | $494.28 | 2021-2025 | |
| Novo Nordisk INC | $443.19 | 2021-2024 | Rybelsus, Ozempic |
| Abbvie INC. | $435.06 | 2021-2024 | |
| Glaxosmithkline, LLC. | $408.47 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Xeris Pharmaceuticals, INC. | $394.64 | 2021-2025 | Recorlev, Gvoke Hypopen |
| Boehringer Ingelheim Pharmaceuticals, INC. | $324.51 | 2021-2024 | Jardiance |
| Lilly USA, LLC | $305.29 | 2021-2024 | Mounjaro, Jardiance |
| Amgen INC. | $297.70 | 2021-2025 | Evenity, Prolia, Krystexxa |
| Merck Sharp & Dohme LLC | $238.33 | 2021-2023 | Verquvo, Belsomra |
| Amarin Pharma, INC. | $204.37 | 2021-2022 | |
| Abbott Laboratories | $200.30 | 2022-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Dexcom, INC. | $151.62 | 2022-2023 | Dexcom G6 Transmitter |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $140.47 | 2023-2024 | Caplyta |
| Pfizer INC. | $130.03 | 2021-2024 |
Show all 35 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wendy Stevens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.